Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-10T15:22:07.044Z Has data issue: false hasContentIssue false

Depression and health-related quality of life in critical COVID-19 survivors

Published online by Cambridge University Press:  01 September 2022

J. Silva*
Affiliation:
Faculty of Medicine University of Porto (FMUP), Fmup, Porto, Portugal
S. Martins
Affiliation:
Faculty of Medicine - University Porto, Department Of Clinical Neuroscience And Mental Health And Center for health technology and services research (cintesis), Porto, Portugal
A.R. Ferreira
Affiliation:
Faculty of Medicine - University Porto, Department Of Clinical Neuroscience And Mental Health And Center for health technology and services research (cintesis), Porto, Portugal
J. Fernandes
Affiliation:
Centro Hospitalar Universitário São João (CHUSJ), Intensive Care Medicine Department, Porto, Portugal
T. Vieira
Affiliation:
Centro Hospitalar Universitário São João (CHUSJ), Intensive Care Medicine Department, Porto, Portugal
L. Fontes
Affiliation:
Centro Hospitalar Universitário São João (CHUSJ), Intensive Care Medicine Department, Porto, Portugal
N. Reis
Affiliation:
Centro Hospitalar Universitário São João (CHUSJ), Intensive Care Medicine Department, Porto, Portugal
A. Braga
Affiliation:
Centro Hospitalar Universitário São João (CHUSJ), Intensive Care Medicine Department, Porto, Portugal
I. Coimbra
Affiliation:
Centro Hospitalar Universitário São João (CHUSJ), Intensive Care Medicine Department, Porto, Portugal
J.A. Paiva
Affiliation:
Centro Hospitalar Universitário São João (CHUSJ), Intensive Care Medicine Department, Porto, Portugal Faculty of Medicine - University Porto, Department Of Medicine, Porto, Portugal
L. Fernandes
Affiliation:
Faculty of Medicine - University Porto, Department Of Clinical Neuroscience And Mental Health And Center for health technology and services research (cintesis), Porto, Portugal Psychiatry Service, Centro Hospitalar Universitário De São João, Porto, Portugal
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Long-term neuropsychiatric consequences of critical illness are well known. Therefore, it is expected that critical COVID-19 patients might also present several psychiatric symptoms such as depression, with inevitable negative effect on health-related quality of life (HRQoL), commonly used as an indicator of illness and treatment impact.

Objectives

To identify depressive symptoms in critical COVID-19 survivors and to examine its association with HRQoL domains.

Methods

This preliminary study involved critical COVID-19 patients admitted into the Intensive Care Medicine Department (ICMD) of a University Hospital, between October and December of 2020. Patients with an ICMD length of stay (LoS)≤24h, terminal illness, major auditory loss, or inability to communicate at the follow-up time were excluded. From 1-2 months after discharge, all participants were evaluated by telephone at follow-up appointment, with Patient Health Questionnaire (PHQ-9) (depression) and EuroQol 5-dimension 5-level EQ-5D-5L (HRQoL). This study is part of the longitudinal MAPA project.

Results

Eighty-three patients were included with a median age of 63 years (range: 31-86) and the majority were male (63%). The most reported problems on EQ-5D-5L domains were usual activities (82%) and mobility (76%). About 27% presented depressive symptoms, and with more problems of self-care (68%vs41%; p=0.029), pain/discomfort (86%vs49%; p=0.002), and anxiety/depression (96%vs54%; p<0.001).

Conclusions

These preliminary results are in line in previous studies in critical COVID-19 survivors, with depression being associated with worse HRQoL. Bearing this in mind, follow-up approaches with an early screening and treatment of these psychiatric symptoms will be fundamental to optimize the recovery of these patients.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.